Filtros de búsqueda

Lista de obras de

A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia.

artículo científico publicado en 2012

An urologic face of chronic lymphocytic leukemia: sequential prostatic and penis localization

artículo científico publicado en 2013

Chronic Lymphocytic Leukemia After Chronic Myeloid Leukemia in the Same Patient: Two Different Genomic Events and a Common Treatment?

artículo científico publicado en 2012

F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma.

artículo científico publicado en 2014

Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome

artículo científico publicado en 2016

Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study

artículo científico publicado en 2013

Modification of QRS pattern in a patient with AL amyloidosis

artículo científico publicado en 2012

Modulation of CD20 antigen expression after rituximab treatment: a retrospective study in patients with chronic lymphocytic leukemia.

artículo científico publicado en 2010

More on spontaneous regression of chronic lymphocytic leukemia: two new cases and potential role of lamivudine in a further patient with advanced disease and hepatitis B virus infection

artículo científico publicado en 2014

No cross-resistance after sequential use of romiplostim and eltrombopag in chronic immune thrombocytopenic purpura

artículo científico publicado en 2013

Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized study

artículo científico publicado en 2011

Positive effects on hematopoiesis in patients with myelodysplastic syndrome receiving deferasirox as oral iron chelation therapy: a brief review

artículo científico publicado en 2010

Response to recombinant erythropoietin alpha, without the adjunct of granulocyte-colony stimulating factor, is associated with a longer survival in patients with transfusion-dependent myelodysplastic syndromes

artículo científico publicado en 2009

Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.

artículo científico publicado en 2015